T0	Participants 27 46	cervical carcinoma:
T1	Participants 273 342	patients affected by cervical cancer undergoing radical hysterectomy.
T2	Participants 351 445	Consecutive patients affected by stage IB-IIB cervical carcinoma scheduled for radical surgery
T3	Participants 591 645	All patients underwent classical radical hysterectomy.
T4	Participants 772 803	168 patients entered the study.